- All sections
- C - Chemistry; metallurgy
- C07K - Peptides
- C07K 14/315 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
Patent holdings for IPC class C07K 14/315
Total number of patents in this class: 791
10-year publication summary
|
62
|
71
|
56
|
84
|
70
|
55
|
52
|
62
|
62
|
16
|
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Novartis AG | 11238 |
20 |
| Glaxosmithkline Biologicals S.A. | 1701 |
20 |
| Oxford University Innovation Limited | 1421 |
20 |
| Affibody AB | 108 |
15 |
| The Regents of the University of California | 18943 |
13 |
| President and Fellows of Harvard College | 5792 |
12 |
| Kaneka Corporation | 4445 |
11 |
| DuPont Nutrition Biosciences ApS | 575 |
10 |
| Griffith University | 143 |
10 |
| Children's Medical Center Corporation | 1780 |
9 |
| Intervacc AB | 13 |
9 |
| Minervax ApS | 10 |
8 |
| St. Jude Children's Research Hospital | 247 |
8 |
| Chr. Hansen A/S | 979 |
8 |
| Wyeth LLC | 691 |
7 |
| Bioatla, Inc. | 93 |
7 |
| Pfizer Inc. | 3322 |
6 |
| The General Hospital Corporation | 4517 |
6 |
| The Trustees of the University of Pennsylvania | 4122 |
6 |
| Duke University | 2872 |
6 |
| Other owners | 580 |